Abstract
Emotional disorders are common in childhood, and their prevalence sharply increases during adolescence. The Strengths and Difficulties Questionnaire (SDQ) is widely used for screening emotional and behavioural difficulties in children and young people, but little is known about the accuracy of the emotional subscale (SDQ-E) in detecting emotional disorders, and whether this changes over development. Such knowledge is important in determining whether symptom changes across age are due to developmental or measurement differences. This study assessed the validity of the SDQ-E and two individual items (low mood and general worry) in differentiating between cases and non-cases of Major Depressive Disorder (MDD), Generalised Anxiety Disorder (GAD), and other anxiety disorders across ages 7, 10, 13, 15, and 25 years in a UK population cohort. Analyses showed moderate accuracy of the subscale in discriminating cases of MDD (AUC=0.67-0.85), and high accuracy for discriminating cases of GAD (AUC=0.80-0.93) and any anxiety disorder (AUC=0.74-0.83) compared to non-cases. The SDQ-E performed well across ages and sex, and generally performed better than the two individual items. Together our findings validate the SDQ-E as a screen for emotional disorders during childhood, adolescence, and early adulthood, and as a tool for longitudinal research on depression and anxiety disorders.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Wolfson Centre for Young Peoples Mental Health
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
ALSPAC Ethics and Law Committee and the Local Research Ethics Committee of Bristol University gave ethnical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
ArmitageJ{at}cardiff.ac.uk,TseliouF{at}cardiff.ac.uk,RiglinL{at}cardiff.ac.uk,DennisonC1{at}cardiff.ac.uk,EyreO2{at}cardiff.ac.uk,BevanJonesR1{at}cardiff.ac.uk,RiceF2{at}cardiff.ac.uk,ThaparAK{at}cardiff.ac.uk,Thapar{at}cardiff.ac.uk,CollishawS{at}cardiff.ac.uk
Data Availability
The University of Bristol owns the ALSPAC resource. Data can be made available on request to the ALSPAC Executive. Full instructions for applying for data access can be found here: http://www.bristol.ac.uk/alspac/researchers/access/.The ALSPAC study website contains details of all the data that are available (http://www.bristol.ac.uk/alspac/researchers/our-data/).
